Auto-HCT produces 'very deep, robust remissions' in AL amyloidosis – Healio


November 24, 2020

1 min watch


Source/Disclosures


Disclosures:
Sher reports research support from Janssen and Prothena and serves as an advisory board for Alnylam.


We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio spoke with Taimur Sher, MBBS, MD, a hematologist, internist and oncologist at the Mayo Clinic Cancer and Multispecialty Amyloidosis Center, about the effects and potential intolerance issues of auto-hematopoietic stem cell transplantation in amyloid light chain (AL) amyloidosis patients.

Watch the video for more on what’s in the pipeline for AL amyloidosis.

 



READ SOURCE

READ  Government Special Order '57 Chevy Discovered in Alaska - MSN Autos

LEAVE A REPLY

Please enter your comment!
Please enter your name here